Crossref
Utility of Myeloperoxidase and Soluble CD40 Ligand in Predicting Acute Coronary Syndrome at Menoufia University Hospitals
The Egyptian Journal of Hospital Medicine · 01.10.2026 · 105 (1) · 6585-6591
DOI: 10.21608/ejhm.2026.536663 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Egyptian Journal of Hospital Medicine, online erschienen am 01.10.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Utility of Myeloperoxidase and Soluble CD40 Ligand in Predicting Acute Coronary Syndrome at Menoufia University Hospitals. The Egyptian Journal of Hospital Medicine, 105(1), 6585-6591. https://doi.org/10.21608/ejhm.2026.536663
Vancouver
Utility of Myeloperoxidase and Soluble CD40 Ligand in Predicting Acute Coronary Syndrome at Menoufia University Hospitals. The Egyptian Journal of Hospital Medicine. 2026;105(1):6585-6591. doi:10.21608/ejhm.2026.536663
BibTeX
@article{euvimed2026,
title = {Utility of Myeloperoxidase and Soluble CD40 Ligand in Predicting Acute Coronary Syndrome at Menoufia University Hospitals},
journal = {The Egyptian Journal of Hospital Medicine},
year = {2026},
volume = {105},
number = {1},
pages = {6585--6591},
doi = {10.21608/ejhm.2026.536663}
}
EUVIMED